Hepatitis B Therapy
Genomic analysis conducted of anti-hepatitis B virus activity
Published in Gene Therapy Weekly, December 29th, 2005
"HBV causes acute and chronic hepatitis and hepatocellular carcinoma. siRNA and lamivudine have been shown to have anti-HBV effects through different mechanisms."
"However," wrote Y. Guo and colleagues, Tsing Hua University, "assessment of the genome-wide effects of siRNA and lamivudine on HBV-producing cell lines has not been reported, which may provide a clue to interrogate the HBV-cell interaction and to evaluate the siRNA's side effect as a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-12-29)
More Articles from Gene Therapy Weekly
- DNA Damage
Disruption of B-myb reveals novel B-Myb function in response to DNA damage - DNA Research
GW182 and a decapping complex crucial in miRNA-mediated gene silencing - Gene Therapy
Endoribonuclease-prepared short interfering RNAs can silence mammalian genes - Herpesvirus
Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression - RNA Therapy
Small interfering RNA may be more therapeutically efficient than antisense oligonucleotide - Actin
Collapsin response mediator protein-4 regulates F-actin bundling - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
